Thanks to a new deal for access to medicines, which includes commitments to improve uptake and support clinical research, the life sciences sector should feel more optimistic about its ability to operate effectively. And perhaps the most consequential development for global health in 2024 will be the rollout of malaria vaccines. This is incredibly significant as the disease kills more than 600,000 people a year worldwide. See the full King’s Fund article here